Drug Trial Radar · NCT01889862
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
Last checked: Nov 20, 2026Latest source record: May 21, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
215
Actual
Start
Jul 29, 2013
Primary completion
Jan 13, 2016
Study completion Feb 5, 2019
Sponsor
- Lead sponsor
- BioMarin PharmaceuticalBioMarin (BMRN)
- Sponsor type
- Industry
- First posted
- Jul 1, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The BMN 165 clinical development program has been designed to demonstrate the safety and efficacy of BMN 165 in reducing blood Phe concentrations in adults with PKU.
Conditions
- Phenylketonuria (PKU)
Interventions
BMN165 20mg/dayDrug
BMN165 20mg/day self-administered daily
BMN165 40mg/dayDrug
BMN165 40mg/day self-administered daily
PlaceboDrug
Non-drug placebo, self-administered daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the Blood Plasma Phenylalanine (Phe) Concentration at Part 2Time frame: At Part 2 baseline and change from baseline at Part 2 week 8
Locations
29 sites in 1 country. Site status is shown where the registry gives one.
University of California, San Diego Clinical and Translational Research Institute
La Jolla, California
UCSF Benioff Children's Hospital Oakland
Oakland, California
Children's Hospital Colorado
Aurora, Colorado
University of Florida Clinical Research Center
Gainesville, Florida
University of South Florida
Tampa, Florida
Emory Universty, Department of Human Genetics, Division of Medical Genetics
Atlanta, Georgia
Ann and Robert H Lurie Children's Hospital of Chicago
Chicago, Illinois
Indiana CTSI Clinical Research Center
Indianapolis, Indiana
University of Kentucky Medical Center
Lexington, Kentucky
University of Louisville, Kosair Charities Pediatric Clinical Research Unit
Louisville, Kentucky
Boston Children's Hospital
Boston, Massachusetts
Wayne State University Clinical Research Center at the Mott Center
Detroit, Michigan
University of Missouri Health Center
Columbia, Missouri
Washington University Center for Applied Research Sciences
St Louis, Missouri
University of Nebraska Medical Center
Omaha, Nebraska
Cooper Health Systems
Camden, New Jersey
Atlantic Health System - Morristown Medical Center
Morristown, New Jersey
Albany Medical Center
Albany, New York
Icahn School of Medicine at Mount Sinai Medical Center
New York, New York
University Hospitals Case Medical Center
Cleveland, Ohio
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma
Oregon Health and Science University
Portland, Oregon
St. Christopher's Hospital for Children
Philadelphia, Pennsylvania
Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
Vanderbilt Children's Hospital
Nashville, Tennessee
University of Texas Houston Medical School
Houston, Texas
University of Utah Hospital
Salt Lake City, Utah
University of Washinton
Seattle, Washington
Medical College of Wisconsin
Milwaukee, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.